Structures by: Lewis T. C.
Total: 26
5-Ethyluracil
C6H8N2O2
New Journal of Chemistry (2008) 32, 10 1761
a=3.9193(18)Å b=5.754(3)Å c=14.366(7)Å
α=100.027(7)° β=96.109(7)° γ=92.374(8)°
5-Cyanouracil
C5H3N3O2
New Journal of Chemistry (2008) 32, 10 1761
a=9.0098(18)Å b=6.6035(13)Å c=9.1805(18)Å
α=90.00° β=98.124(3)° γ=90.00°
5-Chlorouracil
C4H3ClN2O2
New Journal of Chemistry (2008) 32, 10 1761
a=8.4393(10)Å b=6.8412(8)Å c=9.3679(12)Å
α=90.00° β=104.201(2)° γ=90.00°
5-Bromouracil
C4H3BrN2O2
New Journal of Chemistry (2008) 32, 10 1761
a=8.5680(11)Å b=6.8823(9)Å c=9.5715(12)Å
α=90.00° β=103.440(2)° γ=90.00°
C4 H3 F N2 O2, C7 H5 N
C11H8FN3O2
New Journal of Chemistry (2008) 32, 10 1761
a=7.0460(7)Å b=24.035(2)Å c=6.8640(7)Å
α=90.00° β=116.554(2)° γ=90.00°
C4 H3 F N2 O2 , C H3 N O
C5H6FN3O3
New Journal of Chemistry (2008) 32, 10 1761
a=6.827(4)Å b=6.111(3)Å c=8.424(4)Å
α=90.00° β=90.313(8)° γ=90.00°
C4H6N2O4
C4H6N2O4
CrystEngComm (2003) 5, 2 3
a=5.5028(13)Å b=7.0583(16)Å c=8.2718(19)Å
α=70.112(4)° β=85.814(4)° γ=74.095(4)°
3-Oxauracil
C4H3NO3
CrystEngComm (2005) 7, 69 421
a=7.7407(2)Å b=5.54050(10)Å c=10.4926(2)Å
α=90.00° β=103.6430(10)° γ=90.00°
3-Oxauracil monohydrate
C4H3NO3,H2O
CrystEngComm (2005) 7, 69 421
a=14.4737(3)Å b=6.00300(10)Å c=6.36260(10)Å
α=90.00° β=90.00° γ=90.00°
5-hydroxy-2,4(1H,3H)pyrimidinedione
C4H4N2O3
CrystEngComm (2005) 7, 69 421
a=4.61950(10)Å b=7.04930(10)Å c=7.3452(2)Å
α=88.1690(10)° β=81.5040(10)° γ=86.2450(10)°
C22H8I2O2
C22H8I2O2
Acta Crystallographica Section B (2005) 61, 5 511-527
a=4.2020(10)Å b=20.956(4)Å c=9.276(2)Å
α=90.00° β=100.63(3)° γ=90.00°
C3H4N2O2
C3H4N2O2
Acta Crystallographica Section B (2005) 61, 5 511-527
a=9.3538(7)Å b=12.1757(11)Å c=7.2286(6)Å
α=90° β=104.593(4)° γ=90°
C9H9N3O5
C9H9N3O5
Acta Crystallographica Section B (2005) 61, 5 511-527
a=12.5693(4)Å b=4.85310(10)Å c=17.2663(5)Å
α=90° β=99.1624(15)° γ=90°
Azetidine
C3H7N1
Acta Crystallographica Section B (2005) 61, 5 511-527
a=9.507(3)Å b=9.122(3)Å c=9.790(3)Å
α=90° β=117.469(4)° γ=90°
Triethylenediaminium dichloride dihydrate
C6H14N22,2Cl,2H2O
Acta Crystallographica Section E (2005) 61, 7 o2202-o2204
a=7.1407(8)Å b=8.7188(10)Å c=16.8945(19)Å
α=90.00° β=90.00° γ=90.00°
Butyramide
C4H9NO
Acta Crystallographica Section E (2005) 61, 7 o1985-o1986
a=9.814(3)Å b=5.9232(17)Å c=9.701(3)Å
α=90.00° β=112.070(4)° γ=90.00°
5,5-dihydroxybarbituric acid monohydrate
C4H4N2O5,H2O1
Acta Crystallographica Section E (2004) 60, 10 o1689-o1690
a=6.6730(11)Å b=7.5834(13)Å c=7.6157(13)Å
α=105.401(3)° β=93.134(3)° γ=115.089(2)°
5,5-dihydroxybarbituric acid trihydrate
C4H4N2O5,3H2O
Acta Crystallographica Section E (2004) 60, 10 o1748-o1750
a=9.4614(8)Å b=12.2095(10)Å c=7.2973(6)Å
α=90.00° β=91.4650(10)° γ=90.00°
4-Chloro-1,2-dinitrobenzene--1,4-dioxane (1/1)
C6H3ClN2O4,C4H8O2
Acta Crystallographica Section E (2006) 62, 4 o1662-o1663
a=8.2976(12)Å b=8.7112(13)Å c=8.8015(13)Å
α=103.661(2)° β=103.909(2)° γ=91.718(2)°
Adeninium(2+) dichloride
C5H7N52,2Cl
Acta Crystallographica Section E (2005) 61, 4 o1052-o1054
a=13.4405(11)Å b=6.4774(5)Å c=9.3684(7)Å
α=90.00° β=90.00° γ=90.00°
Guaninium chloride dihydrate
C5H6N5O,Cl,2H2O
Acta Crystallographica Section E (2005) 61, 4 o1023-o1025
a=4.8587(11)Å b=13.228(3)Å c=14.612(3)Å
α=90.00° β=93.862(4)° γ=90.00°
Cyanuric acid dihydrate
C3H7N3O5
Crystal Growth & Design (2005) 5, 3 983
a=12.278(2)Å b=6.6757(11)Å c=8.6678(14)Å
α=90.00° β=115.239(2)° γ=90.00°
Cyanuric acid DMF solvate
C6H10N4O4
Crystal Growth & Design (2005) 5, 3 983
a=6.297(4)Å b=7.674(4)Å c=10.557(6)Å
α=74.940(8)° β=87.597(9)° γ=67.677(8)°
C4H4N2O3
C4H4N2O3
Crystal Growth & Design (2004) 4, 5 979
a=6.7305(18)Å b=14.029(4)Å c=6.2309(16)Å
α=90.00° β=116.368(4)° γ=90.00°
C7H8N2O3
C7H8N2O3
Crystal Growth & Design (2004) 4, 5 979
a=8.0309(14)Å b=11.980(2)Å c=7.8139(13)Å
α=90.00° β=107.038(3)° γ=90.00°
C4H4N2O3
C4H4N2O3
Crystal Growth & Design (2004) 4, 5 979
a=8.0828(11)Å b=12.5828(16)Å c=9.7644(13)Å
α=90.00° β=96.150(2)° γ=90.00°